Insider · CIK 0001965585
Farrell Simon
Files at TRVI (Trevi Therapeutics, Inc.). First filing -, latest -.
Farrell Simon files SEC Form 4 as officer at TRVI (Trevi Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Farrell Simon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | 81,313 0.11% of outstanding | $549k | Mar 10, 2025 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | TRVI Trevi Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Feb 20, 2026 |
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Performance Stock Option (right to buy)derivative | +72,000 | $0.00 | $0 | 110,400 | Jun 3, 2025 |
Questions about Farrell Simon
Answered from the filings on this page, as of the latest one.
Is Farrell Simon buying or selling?
Farrell Simon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Farrell Simon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Farrell Simon has 0.
Where does Farrell Simon file Form 4?
Farrell Simon has filed Form 4 at TRVI (Trevi Therapeutics, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.